Subspecialty surveillance of long-term course of small and moderate muscular ventricular septal defect: heterogenous

Erik L Frandsen, Aswathy V House, Yunbin Xiao

  • 1Division of Pediatric Cardiology, University of Nebraska College of Medicine and Children's Hospital and Medical Center, 8200 Dodge St, Omaha, NE 68114, USA. skutty@unmc.edu.

BMC Pediatrics
|November 6, 2014
PubMed
Abstract

Insights

Pediatric cardiology follow-up for small and moderate muscular ventricular septal defects (mVSD) is common but rarely leads to interventions. Significant provider-based variations in follow-up intensity exist for these benign conditions.

Area of Science:

  • Pediatric Cardiology
  • Echocardiography
  • Congenital Heart Disease

Background:

  • Lack of consensus on pediatric cardiology surveillance for hemodynamically insignificant muscular ventricular septal defects (mVSD).
  • Potential for divergent follow-up practices despite the generally benign natural history of mVSD.

Purpose of the Study:

  • Evaluate variations in mVSD follow-up within an academic pediatric cardiology practice.
  • Determine the frequency of active medical or surgical management resulting from mVSD follow-up.

Main Methods:

  • Retrospective review of 600 echocardiographically diagnosed isolated mVSD cases (2006-2012).
  • Data collection on patient demographics, echocardiographic findings, provider recommendations, and management.
  • Multivariate analysis to identify associations with follow-up recommendations.

Main Results:

  • Most mVSD were small (95%); mean age at diagnosis and follow-up were 15.9 and 25.7 months, respectively.
  • Follow-up visits were frequently recommended (316) but inconsistently accomplished (259), with no associated changes in medical or surgical management.
  • Significant provider-based variation (11-100%) in follow-up recommendations was observed, linked to provider identity, patient age, and mVSD characteristics.

Conclusions:

  • Pediatric cardiology follow-up for moderate or smaller mVSD is common but does not typically result in active management.
  • Substantial and difficult-to-justify inconsistencies in follow-up intensity exist among providers for mVSD.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
540
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
501
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.7K
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
663
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K